Patents
Patents for C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor (148,866)
07/2002
07/23/2002US6423534 Method for eliminating ethanol in exhaust gas
07/23/2002US6423533 Isolation and use of perchlorate and nitrate reducing bacteria
07/23/2002US6423527 Sphingosine-1-phosphate lyase polypeptides, polynucleotides and modulating agents and methods of use therefor
07/23/2002US6423524 Cellulase preparation comprising an endoglucanase enzyme
07/23/2002US6423523 Transforming bacillus species with dna molecule comprising specified nucleotide sequence coding for xylanase comprising depicted amino acid sequence, so species comprises complete xylanase gene expression unit, culturing, recovering xylanase
07/23/2002US6423522 Isolated, stable enzyme capable of hydrolyzing enantiomer of bicyclic gamma-lactam, 2-azabicyclo(2.2.1)hept-5-en-3-one
07/23/2002US6423521 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
07/23/2002US6423515 Identifying site-directed mutation of recombinant plasmid dna necessary to produce nucleic acid encoding ribonuclease, using two pcr reactions in overlapping protocol to generate overlapping nucleic acid fragments and desired nucleic acid
07/23/2002US6423510 Candida boidini dihydroxyacetone synthase promoter
07/23/2002US6423509 Generating transferrin polypeptide; obtain vector containing transferrin polypeptide, transform cell, culture, express vector and recover polypeptide
07/23/2002US6423508 Polynucleotide sequences of human EDG-1c
07/23/2002US6423507 Detecting enzyme inhibitors; obtain protease, incubate with modulator, monitor adjustment in protease activity
07/23/2002US6423504 Human-derived bradeion proteins, DNA coding for the proteins, and uses thereof
07/23/2002US6423316 Anticoagulant fusion protein anchored to cell membrane
07/23/2002CA2365997A1 Novel polypeptide
07/23/2002CA2261569C Method for mass production of antimicrobial peptide
07/23/2002CA2067234C Gram-negative alkaliphilic microorganisms
07/23/2002CA2051092C Method and apparatus for cryopreparation, dry stabilization and rehydration of biological suspensions
07/18/2002WO2002055995A2 Method and system for modeling cellular metabolism
07/18/2002WO2002055992A2 Intrinsically fluorescent, self-multimerizing mhc fusion proteins and complexes thereof
07/18/2002WO2002055725A2 Novel nucleic acids, methods and transformed cells for the modulation of gibberellin production
07/18/2002WO2002055718A2 Assembly and screening of highly complex and fully human antibody repertoire in yeast
07/18/2002WO2002055717A2 Enhanced secretion of a polypeptide by a microorganism
07/18/2002WO2002055716A1 Antibiotics-independent vector for constant high-expression and method for gene expression using the same
07/18/2002WO2002055711A2 Method for the production of pantothenic acid by fermentation
07/18/2002WO2002055709A2 Rhodococcus cloning and expression vectors
07/18/2002WO2002055708A1 POLYPEPTIDE HAVING α-ISOMALTOSYLGLUCOSACCHARIDE SYNTHASE ACTIVITY
07/18/2002WO2002055706A2 Asip-related proteins
07/18/2002WO2002055705A2 Proteins and nucleic acids encoding same
07/18/2002WO2002055700A2 Human genes and gene expression products isolated from human prostate
07/18/2002WO2002055698A2 Transcriptional mediators of blood vessel development and endothelial differentiation
07/18/2002WO2002055695A1 Human glioma antigen and process for preparing the same
07/18/2002WO2002055694A2 Discriminative nucleic acid analysis using clone sequence signatures
07/18/2002WO2002055691A1 Gene encoding aip-1/flash promoter and use thereof
07/18/2002WO2002055679A2 Thermostable lipolytic enzyme variant
07/18/2002WO2002055672A1 Bacteriocin-producing lactococcus lactis that can be used as a starter culture to accelerate cheese ripening
07/18/2002WO2002055671A1 Bacillus subtilis var. chungkookjang producing high molecular weight poly-gamma-glutamic acid
07/18/2002WO2002055670A1 Microbiological method for producing amides
07/18/2002WO2002055561A1 Method for surface display of proteins on genetic carriers
07/18/2002WO2002055557A2 Human proteins and nucleic acids encoding same
07/18/2002WO2002055547A2 Sfrp and peptide motifs that interact with sfrp and methods of their use
07/18/2002WO2002055532A2 Variant growth hormone molecules conjugated with macromolecular compounds
07/18/2002WO2002055108A1 Targeted modification of intracellular compounds
07/18/2002WO2002055098A2 Latency associated peptide for providing latency to pharmaceutically active proteins
07/18/2002WO2002054873A2 Microbiological agents for the control of sea lice
07/18/2002WO2002048349A8 Polypeptide capable of binding to heparin
07/18/2002WO2002033129A3 Nucleic acid amplification controls
07/18/2002WO2002028414B1 Compositions and methods for wt1 specific immunotherapy
07/18/2002WO2002028351A3 Recombinant mucin binding proteins from steptococcus pneumoniae
07/18/2002WO2002020597A3 Human vomeronasal receptor-5
07/18/2002WO2002014482A3 Polyketides and their synthesis
07/18/2002WO2002010411A3 Preparation of a recombinant protein in a prokaryotic host cell by improved codon use
07/18/2002WO2002006311A3 Olfactory g-protein coupled receptor
07/18/2002WO2002002633A3 Transporters and ion channels
07/18/2002WO2001094391A3 Intracellular signaling proteins
07/18/2002WO2001090370A3 Method for microbial production of difructose anhydride iii, micro-organism used therefor and enzyme with inulase ii activity and dna sequences coding therefor
07/18/2002WO2001090328A3 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
07/18/2002WO2001088163A9 Method for producing recombinant expansins
07/18/2002WO2001088137A3 Human myd88 adapter-like protein and functional fragments thereof
07/18/2002WO2001088132A3 Rabies virus-specific neutralizing human monoclonal antibodies and nucleic acids and related methods
07/18/2002WO2001087980A3 Isolated human g-protein coupled receptors, nucleic acid molecules encoding human gpcr proteins, and uses thereof
07/18/2002WO2001085790A3 Mammalian cytokine receptor subunit proteins, related reagents and methods
07/18/2002WO2001083786B1 Stable zymomonas mobilis xylose and arabinose fermenting strains
07/18/2002WO2001083749A3 Gene and sequence variation associated with sensing carbohydrate compounds and other sweeteners
07/18/2002WO2001083525A3 Modified peptides, comprising an fc domain, as therapeutic agents
07/18/2002WO2001081590A3 Protein phosphatases
07/18/2002WO2001081408A3 G-protein coupled receptor (gpcr) agonists and antagonists and methods of activating and inhibiting gpcr using the same
07/18/2002WO2001081377A3 Integrin/adhesion antagonists
07/18/2002WO2001079468A3 Drug metabolizing enzymes
07/18/2002WO2001079282A3 Molecules associated with human reproduction
07/18/2002WO2001070946A3 Methods for in vivo diversification of single genes
07/18/2002WO2001068705A3 Il-17 receptor like molecules and uses thereof
07/18/2002WO2001066747A3 Proteins named fctrx and nucleic acids encoding same
07/18/2002WO2001055309A3 Nucleic acids, proteins, and antibodies
07/18/2002WO2001055304A3 Nucleic acids, proteins, and antibodies
07/18/2002WO2001051520A9 Nogo receptor-mediated blockade of axonal growth
07/18/2002WO2001044514A3 Methods and compositions for identifying morphogenic protein analogs using morphogenic protein responsive inhibitory elements
07/18/2002WO2001005834A9 Human tumor necrosis factor receptors tr13 and tr14
07/18/2002WO2000078972A9 Regulation with binding cassette transporter protein abc1
07/18/2002US20020095024 B7-related nucleic acids and polypeptides useful for immunomodulation
07/18/2002US20020095023 Membrane protein for use in the treatment of allergies, parkinson's, alzheimer's and apoptitic defects
07/18/2002US20020094967 Polynucleotide
07/18/2002US20020094965 Purified and isolated polynucleotide molecules that encode the Chlamydia polypeptides designated glutamate binding protein which can be used in methods to prevent, treat, and diagnose Chlamydia pneumoniae; vaccines
07/18/2002US20020094955 Plasminogen-like polynucleotides, polypeptides, and antibodies
07/18/2002US20020094954 Nucleic acids comprising the neuregulin-1-associated gene 1 (NRG1AG1)
07/18/2002US20020094563 A method of solid state fermentation for nomuraea fungal spores demanding high nutrients
07/18/2002US20020094560 Peptide; for use in human therapeutics and diagnostics; for use in treatment of inflammation, cancer, arteriosclerosis, and psoriasis
07/18/2002US20020094559 Nucleotide sequences coding enzymatic polypeptide for use in the treatment of cardiovascular disorders
07/18/2002US20020094557 Enzymatic polypeptide for use in the generation of terpenes
07/18/2002US20020094556 Enzymatic polypeptide for use in generation of preferential terpenes
07/18/2002US20020094554 Nucleotide sequences encoding the ptsH gene
07/18/2002US20020094551 T2R taste receptors and genes ecncoding same
07/18/2002US20020094340 Chlamydia antigens and corresponding dna thereof
07/18/2002US20020094329 B.subtilis, wherein one or more genes involved in the biosynthesis of isovaleric acids have been modified such that the strain cannot produce substantial amounts of isovaleric acids; improved food flavors
07/18/2002US20020094328 Combination of lactic acid bacteria and its use for the prevention and/or treatment of infections and inflammatory conditions
07/18/2002US20020092773 For production of archaebacterium and prokaryotic/eukaryotic cells in bioreactor
07/18/2002DE10123857A1 Verfahren zum Herstellen von heterologen Proteinen in einem homothallischen Pilz der Familie Sordariaceae A method for producing heterologous proteins in a homothallic fungus of the family Sordariaceae
07/18/2002DE10064983A1 New subtilisin protease from Bacillus alcalophilus, useful e.g. in washing and cleaning compositions, comprises at positions 230, 256 and 259 amino acids Val, Gly and Asn
07/18/2002CA2436876A1 Transcriptional mediators of blood vessel development and endothelial differentiation
07/18/2002CA2434672A1 Sfrp and peptide motifs that interact with sfrp and methods of their use